Evidence map›Paper›PMID 32386061›Full record

ArticleThe Journal of infectious diseases2021

Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort Study.

Jan A Roth, Gorjan Radevski, Catia Marzolini, Andri Rauch, Huldrych F Günthard, Roger D Kouyos, Christoph A Fux, Alexandra U Scherrer, Alexandra Calmy, Matthias Cavassini and 5 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in The Journal of infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 1 country.

Jan A RothDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.
Gorjan RadevskiIBM Research-Zurich, Rüschlikon, Switzerland.
Catia MarzoliniDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.
Andri RauchUniversity Clinic of Infectious Diseases, University Hospital Bern, University of Bern, Bern, Switzerland.
Huldrych F GünthardDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Roger D KouyosDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Christoph A FuxClinic for Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Aarau, Switzerland.
Alexandra U ScherrerDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Alexandra CalmyDivision of Infectious Diseases, University Hospital Geneva, University of Geneva, Geneva, Switzerland.
Matthias CavassiniDivision of Infectious Diseases, University Hospital Lausanne, University of Lausanne, Lausanne, Switzerland.
Christian R KahlertDivision of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.
Enos BernasconiDivision of Infectious Diseases, Regional Hospital Lugano, Lugano, Switzerland.
Jasmina BogojeskaIBM Research-Zurich, Rüschlikon, Switzerland.
Manuel BattegayDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.
Swiss HIV Cohort Study (SHCS)
University of Basel · CHUniversity of Zurich · CHIBM Research - Zurich · CHKantonsspital Aarau · CHKantonsspital St. Gallen · CHOspedale regionale di Lugano · CHUniversity of Bern · CHUniversity of Geneva · CHUniversity of Lausanne · CH

Funding

Swiss National Science Foundation 177499
6 · The paper itself

Abstract

backgroundIt is unclear whether data-driven machine learning models, which are trained on large epidemiological cohorts, may improve prediction of comorbidities in people living with human immunodeficiency virus (HIV).

methodsIn this proof-of-concept study, we included people living with HIV in the prospective Swiss HIV Cohort Study with a first estimated glomerular filtration rate (eGFR) >60 mL/minute/1.73 m2 after 1 January 2002. Our primary outcome was chronic kidney disease (CKD)-defined as confirmed decrease in eGFR ≤60 mL/minute/1.73 m2 over 3 months apart. We split the cohort data into a training set (80%), validation set (10%), and test set (10%), stratified for CKD status and follow-up length.

resultsOf 12 761 eligible individuals (median baseline eGFR, 103 mL/minute/1.73 m2), 1192 (9%) developed a CKD after a median of 8 years. We used 64 static and 502 time-changing variables: Across prediction horizons and algorithms and in contrast to expert-based standard models, most machine learning models achieved state-of-the-art predictive performances with areas under the receiver operating characteristic curve and precision recall curve ranging from 0.926 to 0.996 and from 0.631 to 0.956, respectively.

conclusionsIn people living with HIV, we observed state-of-the-art performances in forecasting individual CKD onsets with different machine learning algorithms.

Indexed as

Machine LearningAdultCohort StudiesFemaleGlomerular Filtration RateHealth Knowledge, Attitudes, PracticeHIV InfectionsHumansMaleMiddle AgedPredictive Value of TestsProspective StudiesRenal Insufficiency, ChronicRisk FactorsSwitzerlandchronic kidney diseasedigital epidemiologyHIVmachine learningprediction

Identifiers

PMID32386061
PMCPMC8514185
OpenAlexW3021066313

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.